A carregar...
Assessing Survival Benefit When Treatment Delays Disease Progression
BACKGROUND: For a potentially lethal chronic disease like cancer, it is often infeasible to compare treatments on the basis of overall survival, so a combined outcome such as progression-free survival (which is the time from randomization to progression or death) has become an acceptable primary end...
Na minha lista:
| Publicado no: | Clin Trials |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995068/ https://ncbi.nlm.nih.gov/pubmed/26908538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774515625990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|